{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:31:03Z","timestamp":1793327463264,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32371443-L .X."],"award-info":[{"award-number":["32371443-L .X."]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013068","name":"Key Technologies Research and Development Program of Guangzhou Municipality","doi-asserted-by":"publisher","award":["2025B03J0143-T .C."],"award-info":[{"award-number":["2025B03J0143-T .C."]}],"id":[{"id":"10.13039\/501100013068","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.biomaterials.2026.124615","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:38:46Z","timestamp":1788795526000},"page":"124615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["Bivalent Se nanovaccines targeting both tumor cells and cancer-associated fibroblast for potent anti-desmoplastic tumor immunotherapy"],"prefix":"10.1016","volume":"338","author":[{"given":"Yunqing","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiying","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxia","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6953-1342","authenticated-orcid":false,"given":"Tianfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biomaterials.2026.124615_bib1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41568-019-0186-9","article-title":"Improving cancer immunotherapy through nanotechnology","volume":"19","author":"Goldberg","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124615_bib2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41568-022-00496-9","article-title":"Cancer nanomedicine","volume":"22","author":"Bhatia","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124615_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41568-025-00847-2","article-title":"Advancing engineering design strategies for targeted cancer nanomedicine","volume":"25","author":"Gomerdinger","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124615_bib4","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124615_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124615_bib6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41571-025-01059-1","article-title":"Understanding and overcoming multidrug resistance in cancer","volume":"22","author":"Ge","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124615_bib7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","article-title":"Therapeutic cancer vaccines: advancements, challenges, and prospects","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124615_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-025-01670-w","article-title":"Cancer vaccines: current status and future directions","volume":"18","author":"Zhou","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124615_bib9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Cancer"},{"issue":"25","key":"10.1016\/j.biomaterials.2026.124615_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202316133","article-title":"Injectable mesocellular foam silica microparticles with a dual role of cell-recruiting scaffolds and intracellular delivery vehicles for enhanced cancer vaccine","volume":"34","author":"Im","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124615_bib11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41577-021-00540-z","article-title":"Fibroblasts as immune regulators in infection, inflammation and cancer","volume":"21","author":"Davidson","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124615_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41575-021-00573-8","article-title":"Origin of CAFs in colorectal cancer","volume":"19","author":"Kotsiliti","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124615_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124615_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41568-023-00549-7","article-title":"The advent of immune stimulating CAFs in cancer","volume":"23","author":"Tsoumakidou","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124615_bib15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12943-022-01670-1","article-title":"Targeting the tumor stroma for cancer therapy","volume":"21","author":"Xu","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124615_bib16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-024-01848-7","article-title":"Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124615_bib17","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.cell.2023.03.016","article-title":"Fibroblasts in cancer: unity in heterogeneity","volume":"186","author":"Chhabra","year":"2023","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124615_bib18","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1158\/2159-8290.CD-24-0131","article-title":"Cancer-associated fibroblasts serve as decoys to suppress NK cell anticancer cytotoxicity in breast cancer","volume":"15","author":"Ben-Shmuel","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biomaterials.2026.124615_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101273","article-title":"The multifaceted contributions of cancer-associated fibroblasts to drug resistance in primary and metastatic tumors","volume":"82","author":"Zhang","year":"2025","journal-title":"Drug Resist. Updates"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124615_bib20","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124615_bib21","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1038\/s41467-022-30634-8","article-title":"Peptide nano-blanket impedes fibroblasts activation and subsequent formation of pre-metastatic niche","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124615_bib22","doi-asserted-by":"crossref","first-page":"12357","DOI":"10.1021\/acsnano.9b04857","article-title":"Reshaping prostate tumor microenvironment to suppress metastasis via cancer-associated fibroblast inactivation with peptide-assembly-based nanosystem","volume":"13","author":"Lang","year":"2019","journal-title":"ACS Nano"},{"issue":"39","key":"10.1016\/j.biomaterials.2026.124615_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202504909","article-title":"Dynamic size-change nanovaccine for enhancing lymph node deep penetration and eliciting robust antitumor immune responses","volume":"37","author":"Liu","year":"2025","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124615_bib24","doi-asserted-by":"crossref","first-page":"7136","DOI":"10.1021\/acsnano.3c11637","article-title":"Self-adjuvanting polyguanidine nanovaccines for cancer immunotherapy","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124615_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122856","article-title":"Recent progress in cancer vaccines and nanovaccines","volume":"314","author":"Poudel","year":"2025","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124615_bib26","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41568-025-00858-z","article-title":"Ageing, immune fitness and cancer","volume":"25","author":"Dolan","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"Suppl 8","key":"10.1016\/j.biomaterials.2026.124615_bib27","doi-asserted-by":"crossref","first-page":"VIII6","DOI":"10.1093\/annonc\/mds256","article-title":"Immuno-oncology: understanding the function and dysfunction of the immune system in cancer","volume":"23","author":"Finn","year":"2012","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124615_bib28","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41590-021-00996-0","article-title":"Selenium-GPX4 axis protects follicular helper T cells from ferroptosis","volume":"22","author":"Yao","year":"2021","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124615_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-00478-8","article-title":"Redox regulation of immunometabolism","volume":"21","author":"Muri","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124615_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100975","article-title":"Selenium nanoparticles regulates selenoprotein to boost cytokine-induced killer cells-based cancer immunotherapy","volume":"35","author":"Liu","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2026.124615_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119377","article-title":"Selenium-containing ruthenium complex synergizes with natural killer cells to enhance immunotherapy against prostate cancer via activating TRAIL\/FasL signaling","volume":"219","author":"Lai","year":"2019","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124615_bib32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3390\/nu13030953","article-title":"Serum selenium level predicts 10-Year survival after breast cancer","volume":"13","author":"Szwiec","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124615_bib33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41392-023-01371-1","article-title":"Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine","volume":"8","author":"Lai","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124615_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.chempr.2025.102776","article-title":"Mucin-defined repulsion domain inspiring precise PEGylation shielding empowers selenium nanovaccines as universal mucosal ones against infections","volume":"12","author":"Lei","year":"2026","journal-title":"Chem"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124615_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202300293","article-title":"Designing selenium nanoadjuvant as universal agent for live-killed virus-based vaccine","volume":"7","author":"Deng","year":"2023","journal-title":"Small Methods"},{"issue":"65","key":"10.1016\/j.biomaterials.2026.124615_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.76896","article-title":"Selenium nanoadjuvant-based extracellular vesicle vaccines with immunohomeostasis regulation properties for combating drug-resistant bacteria infection","volume":"36","author":"Zhang","year":"2026","journal-title":"Adv. Funct. Mater."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124615_bib37","doi-asserted-by":"crossref","first-page":"11623","DOI":"10.1021\/acsnano.0c04188","article-title":"Enhanced cancer DNA vaccine via direct transfection to host dendritic cells recruited in injectable scaffolds","volume":"14","author":"Nguyen","year":"2020","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124615_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124615_bib39","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124615_bib40","article-title":"Oxidative stress in antigen processing and presentation","volume":"4","author":"Chang","year":"2025","journal-title":"MedComm - Oncol"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124615_bib41","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/s41590-024-01970-2","article-title":"Vaccination against rapidly evolving pathogens and the entanglements of memory","volume":"25","author":"Cobey","year":"2024","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124615_bib42","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.cell.2020.11.019","article-title":"The identity of human tissue-emigrant CD8+ T cells","volume":"183","author":"Buggert","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124615_bib43","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.immuni.2026.03.009","article-title":"Spatial organization of tissue-resident memory T cells","volume":"59","author":"Burn","year":"2026","journal-title":"Immunity"},{"issue":"8054","key":"10.1016\/j.biomaterials.2026.124615_bib44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41586-024-08466-x","article-title":"Tissue-resident memory CD8 T cell diversity is spatiotemporally imprinted","volume":"639","author":"Reina-Campos","year":"2025","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124615_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202411361","article-title":"Personalized multi-epitope nanovaccine unlocks B cell-mediated multiple pathways of antitumor immunity","volume":"37","author":"Yan","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124615_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122998","article-title":"Antigen self-presenting dendrosomes swallowing nanovaccines boost antigens and STING agonists codelivery for cancer immunotherapy","volume":"316","author":"Xia","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124615_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123331","article-title":"Bioengineered metastatic cancer nanovaccine with a TLR7\/8 agonist for needle-free intranasal immunization","volume":"321","author":"Jung","year":"2025","journal-title":"Biomaterials"},{"issue":"41","key":"10.1016\/j.biomaterials.2026.124615_bib48","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1002\/adma.201300583","article-title":"Morphologically virus-like fullerenol nanoparticles act as the dual-functional nanoadjuvant for HIV-1 vaccine","volume":"25","author":"Xu","year":"2013","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124615_bib49","doi-asserted-by":"crossref","first-page":"10337","DOI":"10.1021\/acsnano.3c00764","article-title":"Nanovaccine displaying immunodominant T cell epitopes of fibroblast activation protein is effective against desmoplastic tumors","volume":"17","author":"Shin","year":"2023","journal-title":"ACS Nano"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:40:40Z","timestamp":1793324440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226006393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":49,"alternative-id":["S0142961226006393"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124615","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bivalent Se nanovaccines targeting both tumor cells and cancer-associated fibroblast for potent anti-desmoplastic tumor immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124615"}}